Sensus Healthcare Announces Dr. Mark Nestor, M.D., Ph.D. as Clinical Director

Aug 28, 2013, 16:56 ET from Sensus Healthcare

$codeDebug.log("output array of get country targets countryT

BOCA RATON, Fla., Aug. 28, 2013 /PRNewswire/ -- Sensus Healthcare is pleased to announce Dr. Mark Nestor as Clinical Director. Dr. Nestor joins a distinguished panel of Medical Advisory Board Members. He will lead the Company's efforts in the areas of Training, Education, and Clinical research as the Company continues to expand its SRT technology for non-invasive skin cancer treatment for NMSC as well as treatment for Keloid scars.

(Logo: )

Dr. Nestor stated, "We have seen a dramatic increase in skin cancer throughout the world and Dermatologists are on the forefront of developing effective, safe, and cost efficient treatments for this ever emerging epidemic. Superficial radiation therapy (SRT) has been in existence for more than 100 years and was developed by dermatologists for the treatment of non-melanoma skin cancer (NMSC) among other conditions. Over the last 40 years the use of SRT has declined dramatically because of the lack of innovative technology and has been a significant loss to our patients. The SRT 100 provides that needed innovation. I am extremely excited to be named as Clinical Director of the Medical Advisory Board of Sensus Healthcare, the premier innovator in SRT. The SRT 100 offers a tremendous leap in technology, allowing Dermatologists to treat many types of NMSC as well as conditions such as recurrent keloid scars safely, effectively and in their office. The commitment of Sensus Healthcare to Dermatology and patient welfare is clearly paramount and will clearly allow the dermatology community to better care for patients."

"Dr. Nestor is a recognized leader in Dermatology and Skin Research. We are very excited to have Dr. Nestor join our Team," said Joe Sardano, President/CEO of Sensus Healthcare.

Dr. Nestor is a practicing dermatologist in Aventura, Florida where he is Director of the Center for Clinical and Cosmetic Research. Other credits include: Associate Professor of the Dept. of Dermatology and Cutaneous Surgery at the University of Miami, Leonard School of Medicine, Past President of the American Society for Photodynamic Therapy, International Society for Cosmetic and Laser Surgeons, and Florida Society of Dermatology and Dermatologic Surgery. Dr. Nestor received his Ph.D in Experimental Pathology and Immunology from UCLA, his M.D. from UCLA School of Medicine and he completed his Residency in Dermatology at New York University. Dr. Nestor currently chairs the Annual South Beach Symposium.

About Sensus Healthcare:

Sensus Healthcare is a medical device company aimed at treating non-melanoma skin cancer and keloid scars with superficial radiation therapy (SRT).  Our SRT systems automate and complement surgical procedures in order to provide both excellent therapeutic and cosmetic results.   Our mobile, compact SRT-100™ systems are used throughout the world by leading radiation oncologists, plastic surgeons, general surgeons, and dermatologists to bring non-melanoma skin cancer and keloid treatments to more patients in more settings.

Michelle Verina
Public Relations
561-922-5808 Ext. *100

SOURCE Sensus Healthcare